Company Filing History:
Years Active: 2022
Title: Silvana Renner - Innovator in Fusion Protein Therapeutics
Introduction
Silvana Renner is an accomplished inventor based in Zurich, Switzerland, known for her significant contributions to medical science through innovative inventions. She holds a patent associated with the development of fusion proteins that hold promise for therapeutic applications in the treatment of inflammatory diseases.
Latest Patents
Renner's notable patent is titled "Vascular endothelial growth factor/anti-fibronectin antibody fusion proteins." This patent details a novel fusion protein comprising an antibody molecule and a member of the vascular endothelial growth factor family, such as VEGF-C or VEGF-D. The innovative aspect of this fusion protein lies in its ability to target antigens associated with angiogenesis, specifically the ED-A isoform of fibronectin. This fusion protein is particularly relevant in therapeutic contexts for treating various inflammatory conditions.
Career Highlights
Currently working at Philogen S.p.a., a biopharmaceutical company, Renner has focused her research on creating therapies that can effectively address unmet medical needs. Her dedication to advancing the field of therapeutic proteins has positioned her as a key contributor in the industry.
Collaborations
Throughout her career, Silvana Renner has collaborated with prominent figures in her field, including Michael Detmar and Dario Neri. These partnerships highlight her commitment to research and innovation, fostering advancements in the therapeutic applications of fusion proteins.
Conclusion
Silvana Renner’s work embodies the spirit of innovation in the biopharmaceutical sector. Her pioneering patent on fusion proteins represents a significant step forward in the treatment of inflammatory diseases, showcasing her dedication to improving healthcare outcomes through scientific advancement.